Skip to content

Study on dose requirement of dexmedetomidine with the use of Bispectral Index Monitoring

Impact of bispectral index monitoring on dose requirement of dexmedetomidine during total parotidectomy under general anesthesia without use of muscle relaxants. - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/03/064505
Enrollment
20
Registered
2024-03-20
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Bispectral Index Monitoring: In one group of patients the dose of dexemedetomidine will be adjusted with bispectral index monitoring throughout period of surgery Control Intervention1:

Sponsors

Amrita Institute of Medical Sciences
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: -American Society of Anesthesiologists physical status (ASA PS) 2 to 3, -Patients undergoing total parotidectomy with nerve conduction studies

Exclusion criteria

Exclusion criteria: -Patients with basal HR less than sixty per min, -beta blockers, -heart blocks, -hypersensitivity to dexmedetomidine -nasal intubation or fibreoptic intubation

Design outcomes

Primary

MeasureTime frame
To compare the intraoperative dexmedetomidine infusion dose requirement with and without bispectral index (BIS) monitoring in patients undergoing total parotidectomy under general anesthesia without use of muscle relaxants.Timepoint: End of surgery

Secondary

MeasureTime frame
To compare intraoperative patient immobility, hemodynamic responses, sevoflurane & propofol consumption, need for intervention if patient moves, incidence of hypotension, use of vasopressors & time taken for extubation in both groups.Timepoint: patient immobility will be assessed at end of surgery, hemodynamic responses will be assessed every half hourly during surgery, sevoflurane & propofol consumption will be noted at the end of surgery, & the time taken for extubation will be documented at the end of surgery.

Countries

India

Contacts

Public ContactMaharnab Bhuyan

Amrita Institute of Medical Sciences, Kochi

lakshmi.k.238@gmail.com04842856162

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026